ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 355063 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 355063; 2) Community: the network communities that were significantly associated with the response to NSC 355063; 3) Molecule: the relationships between components within communities and NSC 355063; 4) MDR: the compounds that were significantly associated with the NSC 355063.

NSC Compound Enrichment Correlation
NSC 684459 7H-Pyrido[3,2-d][1]benzazepine-6-thione, 4-(4-bromo- phenyl)-5,6-dihydro-2-phenyl- 0.0112113991710615 -0.092009793
NSC 685014 Null 0.0112113991710615 0.29808569
NSC 720248 Null 0.0112113991710615 0.27540221
NSC 722222 Null 0.0112113991710615 0.24622859
NSC 726768 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline 0.0112113991710615 0.098892175
NSC 734977 Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate 0.0112113991710615 -0.4239625
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.0112113991710615 -0.026951763
NSC 756166 GSK312948A 0.0112113991710615 0.35279735
NSC 683557 Camptothecin Derivative 0.0112425217758227 -0.10488869
NSC 726863 6-[4-(1-cyclohexenyl)-1,3-butadiyn-1-yl]-2(2H)-pyranone 0.0112425217758227 0.13458972
Total:69  Current:15    [First] [Prev] [Next] [Last]